Copertina

Heat shock protein 90: biological functions, diseases, and therapeutic targets

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Huiyun Wei, Yingying Zhang, Yilin Jia, Xunan Chen, Tengda Niu, Aniruddha Chatterjee, Pengxing He, Guiqin Hou
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	MedComm
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Protein palmitoylation: biological functions, disease, and therapeutic targets
di: Yan‐Ran Qian, et al.
Pubblicazione: (2025)

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets
di: Shen'er Qian, et al.
Pubblicazione: (2024)

Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
di: Ayesha Nisar, et al.
Pubblicazione: (2024)

Ferroptosis: mechanisms and therapeutic targets
di: Qian Zhou, et al.
Pubblicazione: (2024)

Serotonin signaling: a new player and therapeutic target beyond Long‐haul coronavirus disease
di: Lan Bai, et al.
Pubblicazione: (2024)

Regulation of bone homeostasis: signaling pathways and therapeutic targets
di: Zebin Wu, et al.
Pubblicazione: (2024)

Tumor‐associated exosomes in cancer progression and therapeutic targets
di: Xiaomin Liu, et al.
Pubblicazione: (2024)

Cellular senescence in cancer: molecular mechanisms and therapeutic targets
di: Ping Jin, et al.
Pubblicazione: (2024)

Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases
di: Lan‐Ting Feng, et al.
Pubblicazione: (2024)

Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
di: Xiangpeng Wang, et al.
Pubblicazione: (2024)

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
di: Shaohui Wang, et al.
Pubblicazione: (2024)

Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions
di: Shihao He, et al.
Pubblicazione: (2025)

Tissue‐resident memory T cells in diseases and therapeutic strategies
di: Daoyuan Xie, et al.
Pubblicazione: (2025)

Comprehensive multi‐omics analysis provides biological insights and therapeutic strategies for small‐cell lung cancer
di: Guo Zhao, et al.
Pubblicazione: (2024)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
di: Changping Deng, et al.
Pubblicazione: (2025)

Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances
di: Yunxuan Jia, et al.
Pubblicazione: (2024)

Endoplasmic reticulum stress in diseases
di: Yingying Liu, et al.
Pubblicazione: (2024)

The role of circadian clock in regulating cell functions: implications for diseases
di: Yanke Lin, et al.
Pubblicazione: (2024)

Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies
di: Yunuo Yang, et al.
Pubblicazione: (2024)

Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
di: Ying Lu, et al.
Pubblicazione: (2025)

Atopic dermatitis: pathogenesis and therapeutic intervention
di: Chengcheng Yue, et al.
Pubblicazione: (2024)

Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer
di: Yufeng Li, et al.
Pubblicazione: (2024)

Anoikis in cell fate, physiopathology, and therapeutic interventions
di: Jie Mei, et al.
Pubblicazione: (2024)

Loss‐of‐function variants in RNA binding motif protein X‐linked induce neuronal defects contributing to amyotrophic lateral sclerosis pathogenesis
di: Di He, et al.
Pubblicazione: (2024)

Pulmonary fibrosis: pathogenesis and therapeutic strategies
di: Jianhai Wang, et al.
Pubblicazione: (2024)

Rheumatoid arthritis: pathogenesis and therapeutic advances
di: Ying Gao, et al.
Pubblicazione: (2024)

Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1
di: Zijun Zhang, et al.
Pubblicazione: (2025)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
di: Xiaoting Luo, et al.
Pubblicazione: (2024)

Liver cirrhosis: molecular mechanisms and therapeutic interventions
di: Zihe Dong, et al.
Pubblicazione: (2024)

Posttransplant complications: molecular mechanisms and therapeutic interventions
di: Xiaoyou Liu, et al.
Pubblicazione: (2024)

The multifaceted functions of DNA‐PKcs: implications for the therapy of human diseases
di: Jinghong Wu, et al.
Pubblicazione: (2024)

Nonviral targeted mRNA delivery: principles, progresses, and challenges
di: Xi He, et al.
Pubblicazione: (2025)

Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
di: Yuxi Ma, et al.
Pubblicazione: (2024)

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
di: Lu Zhao, et al.
Pubblicazione: (2024)

Lung regeneration: diverse cell types and the therapeutic potential
di: Yutian Chen, et al.
Pubblicazione: (2024)

Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
di: Li Zhuang, et al.
Pubblicazione: (2024)

Renal cancer: signaling pathways and advances in targeted therapies
di: Aimin Jiang, et al.
Pubblicazione: (2024)

Ocular immune‐related diseases: molecular mechanisms and therapy
di: Yakun Wang, et al.
Pubblicazione: (2024)

Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins
di: Qingquan Zheng, et al.
Pubblicazione: (2024)

Synthetic circRNA therapeutics: innovations, strategies, and future horizons
di: Jingsheng Cai, et al.
Pubblicazione: (2024)